IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FIORENTINI, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.560
EU - Europa 2.648
AS - Asia 2.505
SA - Sud America 544
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 11.317
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.475
CN - Cina 888
SG - Singapore 833
UA - Ucraina 529
IT - Italia 510
BR - Brasile 465
PL - Polonia 394
DE - Germania 329
HK - Hong Kong 269
FI - Finlandia 221
VN - Vietnam 157
GB - Regno Unito 148
FR - Francia 144
IN - India 109
RU - Federazione Russa 106
IE - Irlanda 97
TR - Turchia 95
CA - Canada 37
AR - Argentina 32
BE - Belgio 32
MX - Messico 31
SE - Svezia 27
BD - Bangladesh 26
CZ - Repubblica Ceca 24
ZA - Sudafrica 22
ID - Indonesia 20
LU - Lussemburgo 20
IQ - Iraq 17
NL - Olanda 16
IR - Iran 15
EC - Ecuador 14
JP - Giappone 13
ES - Italia 12
AT - Austria 9
PK - Pakistan 8
UZ - Uzbekistan 8
EG - Egitto 7
MA - Marocco 7
PE - Perù 7
EU - Europa 6
JO - Giordania 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CL - Cile 5
KR - Corea 5
UY - Uruguay 5
KE - Kenya 4
KG - Kirghizistan 4
PA - Panama 4
PY - Paraguay 4
SA - Arabia Saudita 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
CO - Colombia 3
JM - Giamaica 3
LT - Lituania 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
CY - Cipro 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TJ - Tagikistan 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
LB - Libano 1
MD - Moldavia 1
MN - Mongolia 1
MQ - Martinica 1
NO - Norvegia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TO - Tonga 1
Totale 11.317
Salva come PNG Salva come JPEG
Città #
Fairfield 556
Woodbridge 487
Ashburn 412
Singapore 402
Jacksonville 392
Warsaw 391
Houston 325
Chandler 274
Hong Kong 267
Brescia 227
Cambridge 212
Seattle 204
Ann Arbor 196
Beijing 192
Wilmington 192
Princeton 182
New York 163
Los Angeles 149
Nanjing 134
Chicago 131
Helsinki 121
Dublin 97
Buffalo 81
Istanbul 76
Dearborn 70
Munich 70
The Dalles 65
Dallas 53
Ho Chi Minh City 50
Salt Lake City 49
Nanchang 48
Shanghai 46
Milan 45
Moscow 44
Des Moines 42
Hebei 39
Shenyang 39
São Paulo 35
Tianjin 35
San Diego 32
Hanoi 30
Jinan 30
Elk Grove Village 29
Lancaster 29
San Francisco 29
Brussels 28
Changsha 27
London 27
Pune 27
Redondo Beach 26
Santa Clara 25
Turku 24
Jiaxing 23
Tampa 23
San Mateo 22
Secaucus 22
Dong Ket 20
Kunming 19
Poplar 17
San Donà Di Piave 17
Toronto 17
Hangzhou 16
Mexico City 15
Brno 14
Brooklyn 14
Guangzhou 14
Rio de Janeiro 14
Ardabil 13
Dudelange 13
Frankfurt am Main 13
Johannesburg 13
Leawood 13
Sterling 13
Tokyo 12
Belo Horizonte 11
Brasília 11
Jakarta 11
Miami 11
Ningbo 11
Phoenix 11
Verona 11
Denver 10
Montreal 10
Augusta 9
Boston 9
Kocaeli 9
Charlotte 8
Da Nang 8
Fuzhou 8
Lappeenranta 8
Manchester 8
Monmouth Junction 8
Pittsburgh 8
Atlanta 7
Boardman 7
Chennai 7
Isola Vicentina 7
Luxembourg 7
Maceió 7
Norwalk 7
Totale 7.542
Salva come PNG Salva come JPEG
Nome #
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 570
Modulation by chronic stress and ketamine of ionotropic AMPA/NMDA and metabotropic glutamate receptors in the rat hippocampus 313
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 279
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 224
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 210
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 204
Immunotherapy failure in adrenocortical cancer: where next? 194
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 190
Social networks and health status in the elderly: the ‘ANZIANI IN-RETE’ population-based study 190
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 184
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 176
The D3 dopamine receptor: From structural interactions to function. 171
Kainate Receptor RNA Editing is Markedly Altered by Acute Spinal Cord Injury. 171
Palbociclib inhibits proliferation of human adrenocortical tumor cells 168
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 165
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 162
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 152
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization. 149
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 149
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 146
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 145
Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons 143
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 143
Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons 136
Ormoni Anteroipofisari 132
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function 126
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 125
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 124
The NMDA/D1 receptor complex as a new target in drug development 123
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 122
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. 121
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction 120
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 119
Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: Role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine 119
Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression 116
Dopamine D3 receptor heteromerization: Implications for neuroplasticity and neuroprotection 115
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 114
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization 114
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 114
Nerve growth factor regulates dopamine D2 receptor expression in prolactinoma cell lines via p75NGFR-mediated activation of nuclear factor-kB. 113
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 110
D1 receptor properties are modulated by its oligomerization with NMDA receptors 109
Role of dopamine D3R/nAChR heterodimeric complex in the regulation of dopaminergic neurons function. 109
Eterodimerizzazione tra recettori dopaminergici D1 e D3: implicazioni funzionali e farmacologiche 108
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 107
D1 and D3 dopamine receptors form heterooligomers and cointernalization after paired activation of both receptors 105
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 105
Role of dopamine D3R and acetylcholine nicotinic receptor interaction in the regulation of dopaminergic neurons function. 105
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 105
Down-regulation of the D1R/Shp-2/Erk1/2 pathway ameliorates L-DOPA-induced dyskinesia in the 6-Hydroxy-Dopamine rat model of Parkinson's disease. 104
Establishment and characterization of induced pluripotent stem cell (iPSCs) line UNIBSi014-A from a healthy female donor 104
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 103
Neurotrophic effects of cocaine on mouse mesencephalic dopaminergic neurons are mediated by dopamine D3 receptors 102
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 100
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 100
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 100
D1 receptor signalling in basal ganglia function and dysfunctions. 100
Phenotype changes of prolactinomas 99
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 99
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson's disease patients carrying the LRRK2 G2019S mutation 95
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 94
Role of D1 and D3 dopamine receptor heterodimerization in the regulation of the receptor signalling 92
Dopamine agonists produce neurotrophic effects on mesencephalic dopaminergic neurons via dopamine D3 receptor activation 90
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 90
Oligomeric assembly of dopamine D1 and glutamate NMDA receptors: molecular mechanisms and functional implications 89
Downregulation of dopamine D1/ glutamate NMDA receptor complexes in L-DOPA-induced dyskinesia in the rat 88
Functional implications of dopamine D1 and D3 receptor heterodimerization 88
miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine 86
Interactions of Dopamine D1 receptors with D3 receptors and glutamate NMDA receptors 83
Regulation of D1 receptor signalling by direct interaction with the protein tyrosine phosphatase SHP-2 83
Oligomerization and trafficking of the human dopamine transporter: mutational analysis identifies critical domains important for the functional expression of the transporter. 78
Loss of Synaptic D1 Dopamine/N-Methyl-D-aspartate Glutamate Receptor Complexes in L-DOPA-Induced Dyskinesia in the Rat. 78
Receptor dimerization and the regulation of neuronal function 77
Ormoni anteroipofisari 77
Identification and characterization of two nuclear factor-kappaB sites in the regulatory region of the dopamine D2 receptor. 77
Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway 77
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate NMDA receptors 76
Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor–Receptor Interaction and Striatal Function 75
In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons 74
17-β-estradiol potentiates the neurotrophic and neuroprotective effects mediated by the dopamine D3/acetylcholine nicotinic receptor heteromer in dopaminergic neurons 72
Downregulation of dopamine D1/NMDA receptor complexes in the post synaptic densities of dyskinetic rats 72
Regulation of G-protein coupled receptor trafficking by receptor-receptor interaction 71
Identification and characterization of two Nf-kB binding sites in the human dopamine d2 receptor promotor 71
Induced pluripotent stem cells for defining Parkinsonian patient subtypes: a further step toward precision medicine 71
Meccanismo molecolari e cellulari nel Morbo di Parkinson 70
Frailty and cognitive impairment in elderly patients: miRNAs as new biomarkers (MATCH-In project) 70
Dendritic remodeling of hippocampal pyramidal neurons, induced by chronic stress and fast-acting antidepressant ketamine, involves miR-9-5p 70
Role of D1 and D3 dopamine receptor heterodimerization in the regulation of receptor trafficking and function 68
Oligomerization with NMDA receptor as a novel regulatory mechanism of D1 receptor function 67
Farmacologia degli ormoni anteroipofisari 66
Growth factors in pituitary tumors 65
MicroRNAs in frailty associated cognitive impairment MATCH In. 65
Oligomerization of dopamine D1 and glutamate NMDA receptors: a new mechanism regulating striatal function” 62
G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2 62
Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors 60
Generation of human induced pluripotent stem cell lines derived from three Noonan syndrome patients from a single family carrying the heterozygous PTPN11 c.188 A > G (p.Y63C) mutation 59
microRNAs as possible biomarkers of frailty and cognitive impairment: the MATCH-In project 56
microRNAs as new biomarkers in frailty associated with cognitive impairment in elderly patients (MATCH-In project) 55
The Potential Role of miRNAs in Cognitive Frailty 51
Functional impact of CYFIP2 RNA Editing on actin regulation, axon growth, and spinogenesis 41
Totale 11.636
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.519
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021934 0 0 0 0 0 127 123 140 167 132 195 50
2021/2022861 61 130 49 24 6 15 91 42 42 103 70 228
2022/2023771 115 9 18 59 70 225 3 78 122 18 23 31
2023/2024758 56 10 69 73 34 173 27 24 137 27 20 108
2024/20252.143 15 20 9 210 170 182 133 56 169 342 608 229
2025/20262.031 311 463 300 550 363 44 0 0 0 0 0 0
Totale 11.673